Retinal Mechanisms of Refractive Development
视网膜屈光发育机制
基本信息
- 批准号:7582937
- 负责人:
- 金额:$ 32.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AmericanAsiansAutomobile DrivingBehavior TherapyBiochemicalBiochemical FeedbackBiochemical PathwayBlindnessCandidate Disease GeneCellsCharacteristicsChickensContrast SensitivityCountryDataDefectDetectionDevelopmentDiagnosisDimensionsDopamineDown-RegulationEnvironmentEpidemicEyeEye DevelopmentFeedbackFrequenciesGenesGogglesGrowthHumanHyperopiaImageInterferometryInterventionKnowledgeLaboratoriesLengthMeasurementMeasuresMicroarray AnalysisModelingMorphologyMusMutant Strains MiceMutationMyopiaNeuronsOperative Surgical ProceduresOpticsPathway interactionsPhotoreceptorsPopulationPrevalenceRefractive ErrorsResearchRetinaRetinalRetinal ConeRetinal DefectRetinal DetachmentRiskRoleSignal PathwaySignal TransductionTestingTransducinVertebrate PhotoreceptorsVisionVisualVisual AccommodationWorld Health Organizationbasecostdeprivationdesigninsightlensmouse modelmutantnovelpreventprogramspublic health relevanceresearch studyresponseretinal rodstransmission processvisual deprivationvisual feedback
项目摘要
DESCRIPTION (provided by applicant): Post-natal refractive development of the eye matches optical power with axial length to focus the visual image onto the photoreceptors. When successful, the eye reaches emmetropia or zero refractive error. However, ~25% of the US population develops myopia while only 10% develop hyperopia. The prevalence of myopia has reached near epidemic proportions in Asian countries. Progressive myopes and high myopes have increased risk of retinal detachment and blindness. While ~$3.9 billion dollars was spent in 2001 on refractive corrections for distance vision (not including the cost of nearly 1 million refractive surgeries performed), no treatments exist to prevent or arrest the progression of myopia. The mechanisms driving refractive development have been localized to the retina, but the retinal pathways and biochemical signaling remain unknown. Based on the assumption that contrast sensitivity and spatial frequency are characteristics of the visual image that drive this response, we hypothesize that the main retinal pathways involved are the ON and OFF pathways. These pathways are proposed to stimulate unique biochemical signals that suppress default excessive eye growth. Thus, normal refractive development relies on constant biochemical feedback derived from retinal pathways activated by normal visual images. We further hypothesize that abnormalities in the visual environment, retinal pathways, or specific biochemical signals will result in down-regulation of the biochemical signaling which then allows for excess eye growth and myopia. In order to test this hypothesis, (Aim 1) the refractive development of specific mouse models with ON or OFF pathway defects will be tested under normal and form deprived visual conditions. In addition, the possibility that ON or OFF pathways originating from rod or cone photoreceptors may control refractive development will be tested by using mice with only functional rods or cones. Refractive development will be assessed by measurements of refractive error and ocular dimensions. The biochemical signals associated with the ON and OFF pathway will be investigated in Aim 2. We hypothesize that dopamine is a putative ON pathway signal. Thus, dopamine synthesis and release will be examined during refractive development in the ON/OFF pathway mutants as well as determining the consequence of the absence of dopamine on refractive development in a retina-specific dopamine deficient mouse. An OFF pathway biochemical signal will be identified using gene profiling in a mouse model with only functional OFF pathways. Candidate genes will then be tested in OFF pathway mutant mice. These experiments are designed to determine the retinal mechanisms of refractive development, thus identifying novel targets for pharmacological or behavioral interventions that could prevent or retard the development of myopia. PUBLIC HEALTH RELEVANCE: Uncorrected refractive errors represent the leading cause of blindness in the world and are the focus of the World Health Organization Vision 2020 program. In the US, ~25% of the population has myopia and an estimated $3.9 billion is spent annually for refractive correction of distance vision; not including the cost of renewed prescriptions or the nearly 1 million refractive surgeries that are performed annually. The proposed research will reveal new insights into the retinal mechanisms that control refractive development, thus identifying novel targets for new interventions that would prevent or retard refractive errors.
描述(由申请人提供):出生后眼睛的屈光发育使屈光力与眼轴长度相匹配,以将视觉图像聚焦到光感受器上。成功后,眼睛将达到正视或零屈光不正。然而,约25%的美国人口发展近视,而只有10%发展远视。近视的流行在亚洲国家已达到接近流行病的比例。进行性近视和高度近视会增加视网膜脱离和失明的风险。虽然2001年花费了约39亿美元用于远视力的屈光矫正(不包括进行的近100万次屈光手术的成本),但不存在预防或阻止近视进展的治疗方法。驱动屈光发展的机制已经定位于视网膜,但视网膜通路和生化信号仍然未知。基于对比敏感度和空间频率是驱动这种反应的视觉图像的特征的假设,我们假设所涉及的主要视网膜通路是ON和OFF通路。这些途径被提出来刺激独特的生化信号,抑制默认的眼睛过度生长。因此,正常的屈光发育依赖于来自正常视觉图像激活的视网膜通路的恒定生化反馈。我们进一步假设,视觉环境、视网膜通路或特定生化信号的异常将导致生化信号的下调,从而导致眼睛过度生长和近视。为了检验这一假设,(目的1)将在正常和形觉剥夺视觉条件下测试具有ON或OFF通路缺陷的特定小鼠模型的屈光发育。此外,将通过使用仅具有功能性视杆细胞或视锥细胞的小鼠来测试源自视杆细胞或视锥细胞的ON或OFF途径可能控制屈光发育的可能性。将通过测量屈光不正和眼部尺寸来评估屈光发育。与ON和OFF通路相关的生化信号将在目标2中研究。我们假设多巴胺是一个假定的ON通路信号。因此,将在ON/OFF途径突变体的屈光发育期间检查多巴胺合成和释放,以及确定在视网膜特异性多巴胺缺陷小鼠中缺乏多巴胺对屈光发育的影响。将在仅具有功能性OFF途径的小鼠模型中使用基因谱分析来鉴定OFF途径生化信号。然后将在OFF途径突变小鼠中测试候选基因。这些实验旨在确定屈光发展的视网膜机制,从而确定可以预防或延缓近视发展的药理学或行为干预的新靶点。公共卫生相关性:未矫正的屈光不正是世界上致盲的主要原因,也是世界卫生组织2020年愿景计划的重点。在美国,约25%的人口患有近视,估计每年花费39亿美元用于远视力的屈光矫正;不包括重新处方的成本或每年进行的近100万次屈光手术。这项拟议的研究将揭示控制屈光发育的视网膜机制的新见解,从而为预防或延缓屈光不正的新干预措施确定新的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Machelle T. Pardue其他文献
13 Aerobic Exercise Prevents Diabetes-Associated Decrease in GDNF and Enteric Neuropathy in Proximal Colon
- DOI:
10.1016/s0016-5085(13)60009-8 - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Anand Jain;Simon M. Mwangi;Behtash G. Nezami;Brian C. Prall;Machelle T. Pardue;Shanthi Srinivasan - 通讯作者:
Shanthi Srinivasan
Abstracts from the 15th International Myopia Conference
- DOI:
10.1186/s40662-016-0057-3 - 发表时间:
2016-11-01 - 期刊:
- 影响因子:4.000
- 作者:
Alexandra Benavente-Perez;Ann Nour;Tobin Ansel;Kathleen Abarr;Luying Yan;Keisha Roden;David Troilo;Chanyi Lu;Miaozhen Pan;Min Zheng;Jia Qu;Xiangtian Zhou;Christine F. Wildsoet;Fan Lu;Xiangtian Zhou;Jie Chen;Jinhua Bao;Liang Hu;Qinmei Wang;Zibing Jin;Jia Qu;Frances Rucker;Stephanie Britton;Stephan Hanowsky;Molly Spatcher;Hui-Ying Kuo;Ching-Hsiu Ke;I-Hsin Kuo;Chien-Chun Peng;Han-Yin Sun;Ian G. Morgan;Jeremy A. Guggenheim;Rupal L. Shah;Cathy Williams;Jinglei Yang;Peter S. Reinach;Sen Zhang;Miaozhen Pan;Wenfeng Sun;Bo Liu;Fen Li;Xiaoqing Li;Aihua Zhao;Tianlu Chen;Wei Jia;Jia Qu;Xiangtian Zhou;Jun Jiang;Haoran Wu;Fan Lu;Kazuo Tsubota;Hiroko Ozawa;Hidemasa Torii;Shigemasa Takamizawa;Toshihide Kurihara;Kazuno Negishi;Klaus Graef;Daniel Rathbun;Frank Schaeffel;Ladan Ghodsi;William K. Stell;Machelle T. Pardue;Ranjay Chakraborty;Han na Park;Curran S. Sidhu;P. Michael Iuvone;Michael J Collins;Nethrajeith Srinvasalu;Sally A. McFadden;Paul N. Baird;P. Michael Iuvone;Pablo Artal;Pauline Cho;SW Cheung;Pei-Chang Wu;Quan V. Hoang;Sally A. McFadden;Ranjay Chakraborty;Duk C. Lee;Erica G. Landis;Michael A. Bergen;Curran Sidhu;Samer Hattar;P. Michael Iuvone;Richard A. Stone;Machelle T. Pardue;Ravi Metlapally;Ruiqin Li;Qinglin Xu;Hong Zhong;Chenglin Pan;Weizhong Lan;Xiaoning Li;Ling Chen;Zhikuan Yang;Scott A. Read;Seang-Mei Saw;Shi-Jun Weng;Xiao-Hua Wu;Kang-Wei Qian;Yun-Yun Li;Guo-Zhong Xu;Furong Huang;Xiangtian Zhou;Jia Qu;Xiong-Li Yang;Yong-Mei Zhong;Earl L Smith;Baskar Arumugam;Li-Fang Hung;Lisa A. Ostrin;Klaus Trier;Monica Jong;Brien A. Holden;Thomas Chuen Lam;Samantha Shan;Bing Zuo;Sally A. McFadden;Dennis Yan-yin Tse;Jingfang Bian;King-Kit Li;Quan Liu;Chi-ho To;Timothy J. Gawne;John T. Siegwart;Alexander H. Ward;Thomas T. Norton;Xiangtian Zhou;Yan Zhang;Yue Liu;Carol Ho;Eileen Phan;Abraham Hang;Emily Eng;Christine Wildsoet - 通讯作者:
Christine Wildsoet
Machelle T. Pardue的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Machelle T. Pardue', 18)}}的其他基金
相似海外基金
SBP: CAREER: Mechanistic Dehumanization of Asians: Identifying Causes, Consequences, and Countermeasures for a More Inclusive STEM Workforce
SBP:职业:亚洲人的机械性非人化:找出原因、后果和对策,打造更具包容性的 STEM 劳动力
- 批准号:
2237461 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
Continuing Grant
Why has academic public health research on "South Asians" failed to mobilize South Asian knowledge and reduce South Asian health disparities in Canada?
为什么针对“南亚人”的学术公共卫生研究未能调动南亚知识并缩小加拿大的南亚健康差距?
- 批准号:
487912 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
Miscellaneous Programs
Characterizing treatment responses for common lung cancer (LC) subtypes in Latinos and Asians
描述拉丁裔和亚洲人常见肺癌 (LC) 亚型的治疗反应
- 批准号:
10733396 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
Cricketqube - Healthy Ageing for South Asians Through Cricket
Cricketqube - 通过板球让南亚人健康老龄化
- 批准号:
10019774 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Small Business Research Initiative
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
- 批准号:
10705254 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Prejudices and Discrimination Toward Asians and Hispanics During and After COVID-19
COVID-19 期间和之后对亚裔和西班牙裔的偏见和歧视
- 批准号:
10705021 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:
10687521 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:
10687807 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
南亚人的脂蛋白代谢和过度心脏代谢风险
- 批准号:
10539768 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Concordance with Dietary Approaches to Stop Hypertension (DASH) diet score and health outcomes among South Asians in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study
居住在美国的南亚人动脉粥样硬化调节因素 (MASALA) 研究中南亚人的饮食评分与健康结果与控制高血压饮食方法 (DASH) 的一致性
- 批准号:
10386158 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别: